Tailor-made therapy of multi-resistan... - Lung Conditions C...

Lung Conditions Community Forum

56,245 members66,869 posts

Tailor-made therapy of multi-resistant tuberculosis.

2greys profile image
0 Replies

Globally, tuberculosis is the most common bacterial infectious disease leading to death. The pathogen causing tuberculosis, Mycobacterium tuberculosis, has a number of peculiarities. One is that it is growing very slowly. While other typical pathogens, such as pneumococcal and pseudomonads, can already be identified by their growth in the microbiological laboratory in the first 72 hours, several weeks usually pass before tuberculosis bacteria grow in the lab. Thus it often takes one to two months before the efficacy of individual medicines can be tested.

However, these efficacy tests are essential for the effective treatment of multidrug-resistant tuberculosis (MDR-TB), which is becoming increasingly common. In these cases, the pathogen has become resistant, i.e. insensitive, to the best tuberculosis drugs, rifampicin and isoniazid. This is due to changes in the genome, so-called mutations, which almost always occur at the same points in the genome. Treatment of MDR-TB is protracted, costly and frequently associated with side effects.

For the selection of antibiotics in a combination therapy, doctors have so far depended on the results of the drug test after cultivation. “Currently, 15 drugs are available for second-line therapy, of which at least four are used in combination,” explains Prof. Christoph Lange, coordinator of the clinical study at the Research Center Borstel.

dzif.de/en/tailor-made-ther...

Clinical Infectious Diseases. Study Paper:

academic.oup.com/cid/advanc...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Tuberculosis is the forgotten pandemic relying on a 100-year-old vaccine.

By some estimates, 2 billion people are now infected worldwide, and in 2019, around 1.4 million...
2greys profile image

Multi-drug resistant infection spreading globally among cystic fibrosis patients.

A multi-drug resistant infection that can cause life-threatening illness in people with cystic...
2greys profile image

Non tuberculosis Microbacterium. NTM.

Rebecca's story was featured in today's newsletter. I can empathize with her as I have NTM. (None...

4 in 1 blood pressure pill: Safe and much more effective than usual hypertension treatment

High blood pressure is the world’s leading killer but poor rates of blood pressure control remain...
2greys profile image

Yep B4 You Say It B12 Again ... But This Time Scientists Unravel B12 / GA 101 Secrets

Yumi Al Have To ..... Please :O Vitamin Microbiology could combat cancer as professor martin warren...

Moderation team

See all
moderator_AandLUK profile image
moderator_AandLUKAdministrator
AsthmaandLung profile image
AsthmaandLungAdministrator
Claire_ALUK profile image
Claire_ALUKAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.